Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Patients should discuss these medications' possible risks and benefits with their healthcare provider to determine the most appropriate treatment option
Single-Agent GLP-1 Therapy Remains the Clinical Standard Evidence from the SUSTAIN and SURMOUNT clinical trials demonstrates that monotherapy with either tirzepatide or semaglutide produces sustained weight reductions of 1522% when properly dosed over 68 weeks
While hair loss from semaglutide is often temporary, its crucial to assess how this might affect your decision to continue the medication
Semaglutide can add stronger appetite and weight effects for selected patients, along with glucose-lowering through a different pathway
She is dedicated to helping Virginia residents understand their Medicare plan options
US$ 28.54
US$ 25.03
US$ 26.39
US$ 27.37
US$ 21.30
US$ 28.39
US$ 29.80
